Previously named MSologists MasterClass, this course is the ultimate in specialism development and requires attendees to have a strong background and experience in MS as a starting point. Ideal for neurologists and healthcare professionals who already have a specialist interest in MS, this course is suited to those who, for example, are currently prescribing or managing patients on disease-modifying treatments (DMTs), are working in a unit that prescribes MS therapies, or are MS nurse specialists who have been practising for at least three years in that role.
Our in-depth and practically-applicable learning tackles specific issues around the management of MS, such as de-risking MS DMTs or tackling the variation in MS care or service access in the UK. Course attendees are already equipped with a strong understanding of MS, including clinical management, patient experience and optimal treatment and service support.
To complete the course: Delegates must complete all aspects of module 1, the inter-module project, and module 2 to gain their certificate. Projects, which should epitomise learning in practice and focus on an unmet need locally, will be presented to their peers and faculty within module 2.
The course is fully funded including travel allowance for clinicians practising in the UK.
Upcoming MS Advanced MasterClasses
► MS Advanced MasterClass 9 – Module 2
18/11/2020 - 19/11/2020
This activity has been supported by a sponsorship from Biogen Idec Ltd, Roche Products Ltd, Merck Serono Ltd and Sanofi Genzyme. The sponsors have had no control over the educational content of this activity.
► MS Advanced MasterClass 12 – Module 1
04/11/2020 - 06/11/2020
► MS Advanced MasterClass 12 – Module 2
20/05/2021 - 21/05/2021
How are the courses taught?
The courses are taught through a range of learner-centred methods including formal lectures, interactive workshops, and an intermodule project. Additional seminars and learning opportunities will be undertaken more locally with your mentor and through distance learning. Learners must complete an intermodule workplace service project during the six/eight month break before returning to Module 2 to present their findings.
A note from our Academic Director, Prof Gavin Giovannoni:
‘To cement the learning objectives from your first MasterClass module, its essential that you complete a project that builds on that learning.
Choose a project that addresses an unmet need in your local service, and find something that sparks your interest. Talk it through with your mentor – or come find me at module 1. We don’t want you to choose something ‘quick and easy’ or to present a proposal or case discussion. Without this project you cannot pass the course or receive your CPD certificate – but we don’t want you to look at it as a ‘tickbox’ to complete. We want to see you putting you’re learning into practice.
Our ambition is for your projects to be the catalyst for change in your practice – to see them improve outcomes for people with MS.’
Needing some project inspiration or wondering what past delegates have done? Take a look at our Snapshots or read about the work of some of our faculty members from the flagship Parkinson’s Academy established 16 years ago.
What will it cost?
The MS MasterClasses are fully funded for delegates working in the UK, which includes accommodation on the nights during both modules and if required the night prior to each module. Your travel grant will be discussed once your application has been approved and is for UK delegates only.
We welcome international delegates on the MS MasterClasses, however there is a charge of £1000 (incl. VAT) for each place and you are responsible for your own travel arrangements. Your attendance fee will cover accommodation on the nights during both modules, all meals and course materials. International delegates may be able to obtain funding for the MasterClass from a pharmaceutical company – we suggest that you contact your local pharmaceutical representatives.
This activity has been supported by sponsorship from Roche Products Limited, Biogen Idec Limited and Sanofi Genzyme. The sponsors have had no control over the educational content of this activity.